Control of Parasitemia and Survival during Trypanosoma brucei brucei Infection is Related to Strain-Dependent Ability to Produce IL-4

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3518-3526

  Bakhiet, Moiz ^a   Jansson, Liselott ^a   Büscher, Philippe ^d   Holmdahl, Rikard ^c   Kristensson, Krister ^b   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CYTOKINE; INTERLEUKIN 4; MESSENGER RNA; PROTOZOON ANTIBODY; VARIANT SURFACE GLYCOPROTEIN;

AFRICAN TRYPANOSOMIASIS; ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; COMPARATIVE STUDY; DRUG ANTAGONISM; FEMALE; GENETICS; IMMUNOLOGY; IN SITU HYBRIDIZATION; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; PARASITEMIA; PARASITOLOGY; SPECIES DIFFERENCE; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; CYTOKINES; FEMALE; IN SITU HYBRIDIZATION; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PARASITEMIA; RNA, MESSENGER; SPECIES SPECIFICITY; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

EID: 0030587881     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. + T cells suppresses growth of Trypanosoma brucei brucei and interferon-γ production in infected rats. Clin. Exp. Immunol. 81:195.
2. + lymphocytes to IFN-γ secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand. J. Immunol. 37:165.
3. Bakhiet, M., E. Mix, K. Kristensson, H. Wigzell, and T. Olsson. 1993. T cell activation by a Trypanosoma brucei brucei derived lymphocyte triggering factor is dependent on tyrosine protein kinases but not on protein kinase C and A. Eur. J. Immunol. 23:1535.
4. + T cells: a trypanosome-released factor triggers interferon-γ production that stimulates parasite growth. Eur. J. Immunol. 21:2447.
5. Olsson, T., M. Bakhiet, B. Höjeberg, Å. Ljungdahl, C. Edlund, G. Andersson, H. P. Ekre, W. P. Fung Leung, T. Mak, H. Wigzell, U. Fiszer, and K. Kristensson. 1993. CD8 is critically involved in lymphocyte activation by a Trypanosoma brucei brucei released molecule. Cell 72:715.
6. Bakhiet, M., T. Olsson, J. Mhlanga, P. Büscher, N. Lycke, P. Van der Meide, and K. Kristensson. 1996. Human and rodent IFN-γ as a growth factor for Trypanosoma brucei brucei. Eur. J. Immunol. In press.
7. Heinzel, F. P., M. D. Sadick, B. J. Holday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
8. Torrico, F., H. Heremans, M. T. Rivera, E. Van Marck, and A. Billiau. 1991. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626.
9. Reinitz, D. M., and J. M. Mansfield. 1990. T cell independent and T cell dependent B cell responses to exposed variant surface glycoprotein epitopes in trypanosome infected mice. Infect. Immun. 58:2337.
10. Mossman, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different fuctional properties. Annu. Rev. Immunol. 7:145.
11. Schleifer, K. W., H. Filutowicz, L. R. Schopf, and J. M. Mansfield. 1993. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J. Immunol. 150:2910.
12. J. M. Mansfield. 1994. T-cell responses to the trypanosome variant surface glycoprotein: a new paradigm. Parasitol. Today 10:267.
13. Borst, P. 1991. Molecular genetics of antigenic variation. Immunol. Today 12:29.
14. Pays, E., L. Vanhamme, and M. Berberof. 1991. Genetic controls for the expression of surface antigens in African trypanosomes. Annu. Rev. Microbiol. 48:25.
15. Lu, Y., T. Hall, L. S. Gay, and J. E. Donelson. 1993. Point mutations are associated with a gene duplication leading to the blood stream reexpression of a trypanosome metacyclic VSG. Cell 72:397.
16. Black, S. J., C. N. Sendashonga, P. A. Lalor, D. D. Whitelaw, R. M. Jack, W. I. Morrison, and M. Murray. 1983. Regulation of the growth and differentiation of Trypanosoma (Trypanozoon) brucei brucei in resistant (C57B1/6) and susceptible (C3H/He) mice. Parasite Immunol. 5:465.
17. De Gee, A. L. W., R. F. Levine, and J. M. Mansfield. 1988. Genetics of resistance to African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J. Immunol. 140:283.
18. Levine, R. F., and J. M. Mansfield. 1984. Genetics of resistance to African trypanosomes. III. Variant-specific antibody responses of H-2 compatible resistant and susceptible mice. J. Immunol. 133:1564.
19. Kün, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
20. Hjulström, S., A. Landin, L. Jansson, R. Holmdahl, and B. Heyman. 1995. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur. J. Immunol. 25:1469.
21. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
22. Czerkinsky, C., G. Andersson, H. P. Ekre, L. Å. Nilsson, L. Klareskog, and Ö. Ouchterlony. 1988. Reverse ELI-SPOT assay for clonal analysis of cytokine production. I. Enumeration of γ interferon-secreting cells. J. Immunol. Methods 110:29.
23. Mustafa, M. I., P. Diener, B. Höjeberg, P. Van der Meide, and Olsson T. 1991. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31:165.
24. Van der Meide, P. H., M. Dubbeld, K. Vijverberg, T. Kos, and H. Schellekens. 1986. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67:1059.
25. Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other animals using DEAE-cellulose. Exp. Parasitol. 28:521.
26. Kaplow, L. S. 1974. Substitute of benzidine in myeloperoxidase stains. Am. J. Clin. Pathol. 63:451.
27. Dagerlind, Å., K. Friberg, A. J. Bean, and T. Hökfelt. 1992. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98:39.
28. Dijkema, R., H. P. Van der Meide, M. Dubbeld, J. Wubben, and H. Schellekens. 1986. Cloning, expression and purification of rat IFN-γ. Methods Enzymol. 119:441.
29. + T cells. Eur. J. Immunol. 21:1187.
30. Derynck, R., J. A. Jarret, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701.
31. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounsteine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 248:1230.
32. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzdy, P. M. Quinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433.
33. Shirai, T., N. Shimizu, S. Shiojiri, S. Horiguchi, and H. Ito. 1989. Cloning and expression in Echerichia coli of the gene for mouse tumor necrosis factor. DNA 7:193.
34. Gray, P. W., E. Chen, W. L. Tang, and N. Ruddle. 1987. The murine tumour necrosis factor-beta (lymphotoxin) gene sequence. Nucleic Acids Res. 15:3937.
35. Fashena, S. J., W. L. Tang, T. Sarr, and N. H. Ruddle. 1990. The murine lymphotoxin gene promoter: characterization and negative regulation. J. Immunol. 145:177.
36. Ishikawa, H., Y. Shinkai, H. Yagita, C. C. Yue, P. A. Henkart, S. Sawada, H. A. Young, C. W. Reynolds, and K. Okumura. 1989. Molecular cloning of rat cytolysin. J. Immunol. 143:3069.
37. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
38. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shepard, and M. A. Palladino. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571.
39. Fargeas, C., C. You Wu, T. Nakajima, D. Cox, T. Nutman, and G. Delespsse. 1992. Differential effects of transforming growth factor β on the synthesis of Th1-and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22:2173.
40. Rockett, K. A., M. M. Awburn, B. B. Aggarwal, W. B. Cowden, and I. A. Clark. 1992. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect. Immun. 60:3725.
41. Sternberg, J., and F. McGuigan. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741.
42. Finkleman, F., and J. Holmes. 1990. Lymphokine control of immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
43. Cunningham, M. P., K. Van Hoeve, and W. H. R. Lumsden. 1963. Variable infectivity of organisms of T. brucei subgroup during the acute relapsing infection in rats, related to parasitaemia, morphology and antibody response. Annu. Rep. EA. Tryp. Res. Org. 1962:21.
44. Balber, A. E. 1972. Trypanosoma brucei: fluxes of morphological variants in intact and X-irradiated mice. Exp. Parasitol. 31:307.
45. Andrew, M. E., and B. E. Coupar. 1992. Biological effects of recombinant vaccinia virus-expressed interleukin-4. Cytokine 4:281.
46. Trehu, E. G., J. M. Isner, J. W. Mier, D. D. Karp, and M. B. Atkins. 1993. Possible myocardial toxicity associated with interleukin-4 therapy. J. Immunother. 14:348.
47. Prendiville, J., N. Thatcher, M. Lind, R. McIntosh, A. Ghosh, P. Stern, and D. Crowther. 1993. Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer - a phase I toxicity study and pharmacokinetic analysis. Eur. J. Cancer 29:1700.